Thermo's BRIMS-Strategy Under Testing

July 2010. Divide customers and Conquer markets won’t work anymore to drive up sales, increase returns, or beat competitors in mass spectrometry. Research has been changing from vertical, in-house R&D to open innovation. Read about the unit, details of its staff, and criticisms of manufacturers as well as recommendations for improving mass spectrometers by experts from US Institute of Standards and Technology (NIST) or the NIH Cancer Proteomic Technologies Consortium.Reading time: 10 min

Read Now:
1,00 EUR (incl. 7% VAT)

Back to section